---
title: "INT MEDICAL implements the acquisition of Hangzhou Weiqiang Medical 51.7% at a cost of 324 million RMB"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241274552.md"
description: "INT MEDICAL announced the acquisition of a 51.7% stake in Hangzhou Weiqiang Medical Technology from an independent third party. The latter mainly engages in the research, development, manufacturing, and sales of aortic and peripheral vascular interventional medical devices, with a cash consideration of RMB 324 million"
datetime: "2025-05-21T15:16:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241274552.md)
  - [en](https://longbridge.com/en/news/241274552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241274552.md)
---

# INT MEDICAL implements the acquisition of Hangzhou Weiqiang Medical 51.7% at a cost of 324 million RMB

INT MEDICAL (01501.HK) announced the acquisition of 51.7% equity in Hangzhou Weiqiang Medical Technology from an independent third party, which mainly engages in the research, development, manufacturing, and sales of aortic and peripheral vascular interventional medical devices, for a cash consideration of RMB 324 million

### Related Stocks

- [01501.HK](https://longbridge.com/en/quote/01501.HK.md)

## Related News & Research

- [Shanghai INT Medical Instruments Shareholders Unanimously Back 2025 Results and Dividend Plan](https://longbridge.com/en/news/287919910.md)
- [The best cryptocurrency to buy with $1,000 right now](https://longbridge.com/en/news/288175024.md)
- [Greater China Financial Trims Liabilities as It Seeks Share Trading Resumption in Hong Kong](https://longbridge.com/en/news/288417555.md)
- [MicroPort NeuroScientific Expands Share Buy-Back, Citing Undervalued Stock](https://longbridge.com/en/news/288484518.md)
- [08:07 ETQuantiPath Expands Food Safety Expertise with Addition of Dr. Tyler Stephens](https://longbridge.com/en/news/288573288.md)